Xeloda Oral, Trastuzumab, and Pertuzumab Combined Drug Therapy Reduced Cervical Lymphadenopathy and Dermal Involvement in Patient With Recurrent Breast Cancer: Case Report

We report the case of a 42-year-old woman who was diagnosed with breast cancer that recurred 3 years later, with supraclavicular lymphadenopathy and dermal involvement. The main drug used in the therapy was trastuzumab; however, the association of this drug with docetaxel was not able to decrease or...

Descripción completa

Detalles Bibliográficos
Autores principales: Saure Sarría, Victor Manuel, Arencibia, Ariel D., D’Afonseca, Vívian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388084/
https://www.ncbi.nlm.nih.gov/pubmed/32720808
http://dx.doi.org/10.1177/2324709620942606

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388084/
https://www.ncbi.nlm.nih.gov/pubmed/32720808
http://dx.doi.org/10.1177/2324709620942606

Ejemplares similares